Longitudinal study observes comparable ocular surface improvement across Sjogren and non-Sjogren dry eye cohorts, indicating stepped therapy effectively controls corneal damage regardless of etiology.
The majority of patients in this longitudinal, tertiary clinic-based sample demonstrated improvement in their ocular surface staining score by the final visit with escalation in treatment. Treatments used, improvement achieved, and corneal complication rates leading to loss of vision were similar in both SS and non-SS dry eye groups.
No takes yet. Share an insight, caveat, or question.
Cui et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: